BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 28618155)

  • 1. Clinical outcome of cystic fibrosis patients colonized by Scedosporium species following lung transplantation: A single-center 15-year experience.
    Parize P; Boussaud V; Poinsignon V; Sitterlé E; Botterel F; Lefeuvre S; Guillemain R; Dannaoui E; Billaud EM
    Transpl Infect Dis; 2017 Oct; 19(5):. PubMed ID: 28618155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scedosporium apiospermum and Lomentospora prolificans in lung transplant patients - A single center experience over 24 years.
    Vazirani J; Westall GP; Snell GI; Morrissey CO
    Transpl Infect Dis; 2021 Jun; 23(3):e13546. PubMed ID: 33315292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology, clinical manifestations, and outcomes of Scedosporium infections among solid organ transplant recipients.
    Johnson LS; Shields RK; Clancy CJ
    Transpl Infect Dis; 2014 Aug; 16(4):578-87. PubMed ID: 24962102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cluster of scedosporiosis in lung transplant candidates and recipients: The Zurich experience and review of the literature.
    Abela IA; Murer C; Schuurmans MM; Schmitt JW; Muller F; Imkamp F; Mueller NJ; Benden C
    Transpl Infect Dis; 2018 Feb; 20(1):. PubMed ID: 29044831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of Scedosporium species and Lomentospora prolificans in patients with cystic fibrosis in a multicenter trial by use of a selective medium.
    Sedlacek L; Graf B; Schwarz C; Albert F; Peter S; Würstl B; Wagner S; Klotz M; Becker A; Haase G; Laniado G; Kahl B; Suerbaum S; Seibold M; Tintelnot K
    J Cyst Fibros; 2015 Mar; 14(2):237-41. PubMed ID: 25595044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination antifungal therapy for Scedosporium species in cystic fibrosis.
    Bentley S; Davies JC; Carr SB; Balfour-Lynn IM
    Pediatr Pulmonol; 2020 Aug; 55(8):1993-1995. PubMed ID: 32339450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scedosporium apiospermum complex in cystic fibrosis; should we treat?
    Noni M; Katelari A; Kapi A; Stathi A; Dimopoulos G; Doudounakis SE
    Mycoses; 2017 Sep; 60(9):594-599. PubMed ID: 28504471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Scedosporium apiospermum disseminated infection in a single lung transplant recipient].
    Solé A
    Rev Iberoam Micol; 2011; 28(3):139-42. PubMed ID: 21700235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of patients with cystic fibrosis colonized by Scedosporium and Lomentospora species: A longitudinal cohort study.
    Parize P; Fleury M; Poupon-Bourdy S; Persat F; Touzet S; Bienvenu AL; Wallon M; Reix P; Bouchara JP; Durieu I
    Med Mycol; 2023 Jun; 61(6):. PubMed ID: 37263788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salvage therapy with topical posaconazole in lung transplant recipients with invasive Scedosporium infection.
    Solé A; García-Robles AA; Jordá C; Cases Viedma E; Mancheño N; Poveda-Andrés JL; Reig Mezquida JP; Pemán J
    Am J Transplant; 2018 Feb; 18(2):504-509. PubMed ID: 29116676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perspectives on Scedosporium species and Lomentospora prolificans in lung transplantation: Results of an international practice survey from ESCMID fungal infection study group and study group for infections in compromised hosts, and European Confederation of Medical Mycology.
    Rammaert B; Puyade M; Cornely OA; Seidel D; Grossi P; Husain S; Picard C; Lass-Flörl C; Manuel O; Le Pavec J; Lortholary O;
    Transpl Infect Dis; 2019 Oct; 21(5):e13141. PubMed ID: 31283872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disseminated Scedosporium apiospermum infection in a cystic fibrosis patient after double-lung transplantation.
    Symoens F; Knoop C; Schrooyen M; Denis O; Estenne M; Nolard N; Jacobs F
    J Heart Lung Transplant; 2006 May; 25(5):603-7. PubMed ID: 16678041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical associations and prevalence of Scedosporium spp. in Australian cystic fibrosis patients: identification of novel risk factors?
    Blyth CC; Middleton PG; Harun A; Sorrell TC; Meyer W; Chen SC
    Med Mycol; 2010 Nov; 48 Suppl 1():S37-44. PubMed ID: 21067328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nebulized voriconazole in infections with Scedosporium apiospermum--case report and review of the literature.
    Holle J; Leichsenring M; Meissner PE
    J Cyst Fibros; 2014 Jul; 13(4):400-2. PubMed ID: 24263169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invasive Scedosporium spp. and Lomentospora prolificans infections in pediatric patients: Analysis of 55 cases from FungiScope® and the literature.
    Seidel D; Hassler A; Salmanton-García J; Koehler P; Mellinghoff SC; Carlesse F; Cheng MP; Falces-Romero I; Herbrecht R; Jover Sáenz A; Klimko N; Mareş M; Lass-Flörl C; Soler-Palacín P; Wisplinghoff H; Cornely OA; Pana Z; Lehrnbecher T
    Int J Infect Dis; 2020 Mar; 92():114-122. PubMed ID: 31863876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infections due to Scedosporium apiospermum and Scedosporium prolificans in transplant recipients: clinical characteristics and impact of antifungal agent therapy on outcome.
    Husain S; Muñoz P; Forrest G; Alexander BD; Somani J; Brennan K; Wagener MM; Singh N
    Clin Infect Dis; 2005 Jan; 40(1):89-99. PubMed ID: 15614697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scedosporium prolificans pericarditis and mycotic aortic aneurysm in a lung transplant recipient receiving voriconazole prophylaxis.
    Sayah DM; Schwartz BS; Kukreja J; Singer JP; Golden JA; Leard LE
    Transpl Infect Dis; 2013 Apr; 15(2):E70-4. PubMed ID: 23387799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective multicenter German study on pulmonary colonization with Scedosporium /Lomentospora species in cystic fibrosis: Epidemiology and new association factors.
    Schwarz C; Brandt C; Antweiler E; Krannich A; Staab D; Schmitt-Grohé S; Fischer R; Hartl D; Thronicke A; Tintelnot K
    PLoS One; 2017; 12(2):e0171485. PubMed ID: 28178337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N(α)-methyl coprogen B, a potential marker of the airway colonization by Scedosporium apiospermum in patients with cystic fibrosis.
    Bertrand S; Bouchara JP; Venier MC; Richomme P; Duval O; Larcher G
    Med Mycol; 2010 Nov; 48 Suppl 1():S98-107. PubMed ID: 21067336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fungal infection of cystic fibrosis patients - single center experience.
    Garczewska B; Jarzynka S; Kuś J; Skorupa W; Augustynowicz-Kopeć E
    Pneumonol Alergol Pol; 2016; 84(3):151-9. PubMed ID: 27238177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.